tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Emily Bodnar, 349 are a BUY (89.26%), 42 are a HOLD (10.74%).
Analyst Emily Bodnar, currently employed at HC WAINWRIGHT, carries an average stock price target met ratio of 29.11% that have a potential upside of 47.33% achieved within 100 days.
Emily Bodnar’s has documented 678 price targets and ratings displayed on 34 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on TGTX, TG Therapeutics at 01-Sep-2026.
Analyst best performing recommendations are on INKT (MINK THERAPEUTICS).
The best stock recommendation documented was for INKT (MINK THERAPEUTICS) at 7/14/2025. The price target of $35 was fulfilled within 1 day with a profit of $5.61 (13.81%) receiving and performance score of 138.14.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 09-Aug-2023
$48
$0.45 (0.95%)
$48
3 years 2 months 14 days ago
(09-Aug-2023)
1/8 (12.5%)
$0.45 (0.95%)
85
Hold Since 26-Jun-2023
$56
3 years 3 months 27 days ago
(26-Jun-2023)
0/1 (0%)
$27.35 (95.46%)
Buy Since 22-May-2023
$48
3 years 4 months 2 days ago
(21-Jun-2023)
0/2 (0%)
$1.56 (3.36%)
Buy Since 14-Sep-2022
$48
$0.45 (0.95%)
$68
3 years 4 months 3 days ago
(20-Jun-2023)
1/3 (33.33%)
$1.56 (3.36%)
27
Hold Since 24-May-2023
$48
$0.45 (0.95%)
$38
3 years 4 months 3 days ago
(20-Jun-2023)
1/2 (50%)
$1.56 (3.36%)
27
Which stock is Emily Bodnar most bullish on?
Which stock is Emily Bodnar most reserved on?
What Year was the first public recommendation made by Emily Bodnar?
